Dae Joong Kim

Dr. Dae Joong Kim

orcid

Biography

I am a Research Assistant Professor of Orthopaedics with two decades of work at the intersection of tumor immunology, stem cell biology, vascular/stromal biology, and epigenetic control. My goal is to turn the immunosuppressive tumor microenvironment (TME) into a setting that supports durable anti-tumor immunity. To that end, my research has mapped how endothelial and stromal programs, extracellular matrix (ECM) remodeling, and epigenetic mechanisms drive tumor progression and immune exclusion, and how these processes can be redirected for therapy. Early studies from my group defined cytoskeletal and polarity checkpoints that govern vascular lumen formation and stromal plasticity and identified TGFβ-driven endothelial-to-mesenchymal transition and fibroblast conversion as tractable contributors to an immunosuppressive stroma utilizing lenti, and adenovirus. Building on this foundation, we showed that “vascular priming” can induce a selective cytokine program that permits CD8⁺ T-cell entry into otherwise immune-excluded tumors (Nat. Commun, 2023). Complementary work revealed how periostin⁺ stromal cells coordinate lymphovascular invasion (Cancer Res, 2023) and how Spon1⁺ inflammatory monocytes remodel collagen to promote metastasis (JCI Insight, 2024). Most recently, I synthesized therapeutic opportunities across the DNMT axis (Curr Oncol, 2025), reflecting a broader focus on actionable epigenetic regulation within the TME.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.